CoLig-10
Natural health product licensed in Canada
- Licence holder
- The Tetra Corporation
- NPN or DIN-HM
- 80082840
- Status
- Active licence
- Licence date
- 2 February 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Aloe vera (L.) Burm. f.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcumine | 22 mg | Not calculated |
| Collagène hydrolysé Source : Collagène hydrolysé | 75 mg | Not calculated |
| Collagène hydrolysé Source : bovine skin/hide split | 75 mg | Not calculated |
| Bêta-carotène Source : bêta-carotène | 750 mcg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 150 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 13:1 Dry plant equivalent : 650 mg Potency : 85 % Oligomeric proanthocyanidins | 50 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 60 mg | 120,000 µg |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 10.05 mg AT | Not calculated |
| Niacinamide Source : Niacinamide | 20 mg | Not calculated |
| Aloe vera Source : Gel de la feuille Extract : Matériel brut sec Extraction ratio : 200:1 Dry plant equivalent : 20,000 mg | 100 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 400 mg Potency : 15 % Epigallocatechin 3-gallate | 50 mg | Not calculated |
| Acide aminoacétique Source : Glycine | 50 mg | Not calculated |
| L-Proline Source : L-Proline | 50 mg | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome | 22 mg | Not calculated |
| L-Glutathione Source : Glutathione | 10 mg | Not calculated |
| trans-Resvératrol Source : Resvératrol | 5 mg | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 5 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 2.5 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 2.5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Poudre d'Oryza Sativa (Riz), Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provitamin A for the maintenance of good health. Provitamin A to help maintain eyesight, skin, membranes and immune function. Provitamin A to help in the development and maintenance of night vision. Provitamin A to help in the development and maintenance of bones and teeth. Helps in the development and maintenance of bones, cartilage, teeth and/or gums. Helps in connective tissue formation. Helps in wound healing. Source of/An antioxidant for the maintenance of good health. Source of/An antioxidant that decreases the adverse effects of free radicals on normal physiological functions. Source of/An antioxidant that helps to reduce free radicals and lipid oxidation in body tissues. Source of/An antioxidant that helps (to): a) fight / b) protect (cells) against / c) reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Helps to maintain immune function. Source of/An antioxidant that protects the fat in body tissues from oxidation. Helps to prevent vitamin E deficiency. Helps normal growth and development. Helps in energy metabolism and tissue formation. Helps to prevent vitamin B3 deficiency. Provides antioxidants for the maintenance of good health. Workout supplements. Athletic support. Source of (an) amino acid(s) involved in muscle protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80082840
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.